LUCAS VERDI ANGELOCCI

Projetos de Pesquisa
Unidades Organizacionais
Cargo

Resultados de Busca

Agora exibindo 1 - 3 de 3
  • Resumo IPEN-doc 29201
    Development of a new material to encapsulate phosphorus-32 for use in brachytherapy
    2022 - TEODORO, LARA E.H.; TALACIMON, CRISTHIAN F.; ROSERO, WILMMER A.A.; RIGO, MARIA E.Z.; RODRIGUES, PRISCILA S.; NOGUEIRA, THUANY C.; ANGELOCCI, LUCAS V.; ROSTELATO, MARIA E.C.M.
    The term cancer refers to a set of malignant diseases that have in common the disordered growth of mutated cells, which can invade adjacent tissues or distant organs[1]. In 2020, cancer of the central nervous system (CNS) represented 1.6% of all new malignant tumor cases in the world, and about 2.5% of all new cancer deaths[2]. A promising radioactive source for use in intracavitary brachytherapy is phosphorus-32. This source has been prominent as a minimally invasive treatment for craniopharyngiomas and in the treatment of metastatic bone diseases in general[3]. To encapsulate phosphorus-32 and make it a viable radioactive source for use in medicine, some methods have emerged. In this work, we are developing a fabric soaked in industrial latex for this purpose, as this source comes in the form of orthophosphoric acid in aqueous solution and as industrial latex is soluble in water. Tests carried out so far show that the material supports orthophosphoric acid while is still malleable, which is essential for treating spinal cancer.
  • Artigo IPEN-doc 27887
    Dose-rate constant and air-kerma strength evaluation of a new 125I brachytherapy source using Monte-Carlo
    2021 - PRIMO, C.O.; ANGELOCCI, L.V.; KARAM JUNIOR, D.; ZEITUNI, C.A.; ROSTELATO, M.E.C.M.
    Brachytherapy is a modality of radiotherapy which treats tumors using ionizing radiation with sources located close to the tumor. The sources can be produced from several radionuclides in various formats, such as Iodine-125 seeds and Iridium-192 wires. In order to produce a new Iodine-125 seed in IPEN/CNEN and ensure its quality, it is essential to describe the seed dosimetry, so when applied in a treatment the lowest possible dose to neighboring healthy tissues can be reached. The report by the AAPM’s Task Group 43 U1 is a document that indicates the dosimetry procedures in brachytherapy based on physical and geometrical parameters. In this study, dose-rate constant and air-kerma strength parameters were simulated using the Monte Carlo radiation transport code MCNP4C. The air-kerma strength is obtained from an ideal modeled seed, since its actual value should be measured for seeds individually in a specialized lab with a Wide-Angle Free-Air Chamber (WAFAC). Dose-rate constant and air-kerma strength are parameters that depends on intrinsic characteristics of the source, i.e. geometry, radionuclide, encapsulation, and together they define the dose-rate to the reference point. Radial dose function describes the dose fall-off with distance from the source. This study presents the values found for these parameters with associated statistical uncertainty, and is part of a larger project that aims the full dosimetry of this new seed model, including experimental measures.
  • Artigo IPEN-doc 25055
    Mesh-based human eye anatomy for Monte Carlo dose calculation
    2018 - ANGELOCCI, LUCAS V.; YORIYAZ, HELIO
    Purpose: The purpose of this work is to explore the capability of the MCNP6 unstructured mesh geometry resources to create an eye and tumor anatomic model for ophthalmic brachytherapy dosimetry. Methods: Abaqus/CAE software was utilized to construct three anatomic eye models using first order tetrahedral mesh elements: a model with a 2 cm in diameter deep tumor; a model with a 1.2 cm in diameter deep tumor; and a model with a 1.2 cm superficial tumor. 2 cm and 1.2 cm COMS applicators fully loaded with Amersham 6711125I seeds were coupled to the eye models for dose calculation using the MCNP6 code. The dose values in the structures of the eye were compared to those obtained using analytical models. Results: Unstructured mesh model has small differences (maximum of 3.4%) in the mass values of the components of the eye comparing to those obtained in the analytical model. Excluding the optical nerve wall, all dose differences were beneath 4% for all structures. The overall dose in the eye agrees within 2% between different models. Conclusions: The feasibility of using unstructured mesh based geometries to model fine structures of the eye has been verified in this study. It was possible to create adequately the anatomic model of the human eye with reproducible dose values compared to reference values.